FETP Dashboard
Button
X
FETP Dashboard
Image
Click on the dark blue Areas
Country Name AFGHANISTAN
Explore More

Year of Establishment

2019

Accreditation Status

NA

Visit Afghanistan FETP

Click here

Advanced Grads

NA

Intermediate Grads

107

Basic Grads

NA

Outbreak Investigations Conducted

178

Manuscripts Published

10

Participations in International Conferences

10

________________

Back To Map
Country Name BANGLADESH
Explore More

Year of Establishment

2013

Accreditation Status

NA

Visit Bangladesh FETP

Click here

Advanced Grads

55

Advanced Grads-Vet

6

Intermediate Grads

33

Basic Grads

97

Outbreak Investigation Conducted

212

Manuscripts Published

8

Participations in International Conferences

30

_

Back To Map

Year of Establishment

1993

Accreditation Status

Accredited

Visit Egypt FETP

Click here

Advanced Grads

174

Intermediate Grads

35

Basic Grads

147

Outbreak Investigation Conducted

200

Manuscripts Published

66

Participations in International Conferences

50

_

Back To Map

Year of Establishment

2010

Accreditation Status

NA

Visit Iraq FETP

Click here

Advanced Grads

66

Intermediate Grads

87

Basic Grads

248

Outbreak Investigation Conducted

387

Manuscripts Published

116

Participations in International Conferences

143

_

Back To Map
Year of Establishment 1998
Accreditation Status NA
Visit Jordan FETP Click here

Advanced Grads

128

Intermediate Grads

NA

Basic Grads

17

Outbreak Investigations Conducted

98

Manuscripts Published

29

Participations in International Conferences

338

_

Back To Map
Year of Establishment 2022
Accreditation Status NA
Visit Lebanon FETP Click here

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

28

Outbreak Investigation Conducted

NA

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map
Year of Establishment 2023
Accreditation Status NA
Visit Libya FETP NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

54

Outbreak Investigations Conducted

4

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map

Year of Establishment

2010

Accreditation Status

Accredited

Visit Morocco FETP

Click here

Advanced Grads

114

Intermediate Grads

50

Basic Grads

30

Outbreak Investigation Conducted

215

Manuscripts Published

12

Participations in International Conferences

70

_

Back To Map
Year of Establishment 2022
Accreditation Status NA
Visit Oman FETP NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

22

Outbreak Investigation Conducted

NA

Manuscripts Published

NA

Participations in International Conferences

NA

_

Back To Map

Year of Establishment

2006

Accreditation Status

Accredited

Visit Pakistan FELTP

Click here

Advanced Grads

246

Intermediate Grads

NA

Basic Grads

296

Outbreak Investigation Conducted

719

Manuscripts Published

166

Participations in International Conferences

240

_

Back To Map
Country Name QATAR

Year of Establishment

2022

Accreditation Status

NA

Visit Qatar FETP

NA

Advanced Grads

NA

Intermediate Grads

NA

Basic Grads

23

Outbreak Investigations Conducted

6

Manuscripts Published

26

Participations in International Conferences

25

_

Back To Map
Country Name SAUDI ARABIA
Explore More

Year of Establishment

1989

Accreditation Status

NA

Visit Saudi Arabia FETP

Click here

Advanced Grads

189

Intermediate Grads

NA

Basic Grads

60

Outbreak Investigations Conducted

141

Manuscripts Published

397

Participations in International Conferences

464

_

Back To Map

Year of Establishment

2017

Accreditation Status

NA

Visit Sudan FETP

Click here

Advanced Grads

14

Intermediate Grads

11

Basic Grads

112

Outbreak Investigations Conducted

59

Manuscripts Published

5

Participations in International Conferences

6

_

Back To Map

Year of Establishment

2017

Accreditation Status

NA

Visit Tunisia FETP

Click here

Advanced Grads

NA

Intermediate Grads

51

Basic Grads

37

Outbreak Investigation Conducted

33

Manuscripts Published

1

Participations in International Conferences

3

_

Back To Map

Year of Establishment

2011

Accreditation Status

NA

Visit Yemen FETP

Click here

Advanced Grads

53

Intermediate Grads

24

Basic Grads

450

Outbreak Investigations Conducted

59

Manuscripts Published

61

Participations in International Conferences

2

_

Back To Map
March 31, 2022
EMPHNET Holds its Nineteenth Webinar “COVID-19 and Cancer”

Over the past two years, the world has witnessed the prevalence of the COVID-19 pandemic. The rapid international spread of COVID-19 has posed a global health threat and was considered a “Public Health Emergency of International Concern.” Thus, the occurrence of COVID-19 brings challenges to senior citizens or the elderly and those with underlying comorbidities, including Cancer. In fact, this infectious disease has a long-lasting impact on Cancer diagnosis, treatment, and research. Research has shown that Cancer patients have a higher risk of getting COVID-19 and they tend to have more severe symptoms.

To shed light on this issue, the Eastern Mediterranean Public Health Network (EMPHNET) held a webinar titled “COVID-19 and Cancer” on Tuesday, March 29, 2022. The session focused on the impact of COVID-19 on Cancer patients, and research. It also displayed the effects of COVID-19 on the provision of Cancer management to patients, while highlighting lessons learned from COVID-19 vaccines, and the prospects of developing new therapies for different types of Cancer.  

The webinar was led by a panel of experts including Professor of Cancer Medicine, Consultant Physician, Oxford University, UK. Associate Editor in Chief, Journal of Global Oncology, Prof. David Kerr; Consultant Oncologist, Editor in Chief, The Gulf Federation of Cancer Control, State of Kuwait, Prof. Khaled Al Salih; and Director General of King Hussein Cancer Foundation, Ms. Nisreen Qatamish. In addition, the session was facilitated by Professor, Pathology Department, College of Medicine, University of Baghdad, Dr. Nada Alwan; and Public Health Expert, Associate Professor, Baghdad University, Iraq, Dr. Faris Lami.

In his opening remarks, Dr. Lami welcomed the webinar participants and speakers, and introduced Dr. Alwan as the second facilitator. The facilitators then presented the webinar’s focus, objectives, and speakers. Dr. Lami then handed the microphone over to Prof. Kerr, who presented The New Normal in Clinical research.

Prof. Kerr began his presentation by giving an overview of the UK Coronavirus Cancer Monitoring Project and he shared statistics on patients’ clinical outcomes and the effect of chemotherapy four weeks after being infected with COVID-19. He also said that the lack of clinical staff with the ability to conduct trial activities and visits, the revised use of clinical facilities, and the reprioritization of diagnostic tools and facilities such as imaging and laboratory analysis caused problems for ongoing clinical trials during COVID-19. Prof Kerr also shed light on COVID-19 Research and presented HDACi: Potential Uses as an Anti-Viral Agent, and Emactuzumab: Potential Uses as an Anti-Viral Agent.

The second presenter, Dr. AlSalih talked about the COVID-19 and Cancer Situation in Kuwait. He began by providing a brief overview of the COVID-19 situation in Kuwait, as well as the situation with cancer during the pandemic and the Kuwait Cancer Control Center (KCCC). Dr. AlSalih also highlighted the role of doctors and the treatment of Cancer patients during the pandemic. He then spoke about the role of Non-Governmental Organizations (NGOs) in the fight against Cancer.

From her end, Ms. Qatamish, spoke about Cancer Care Provision and recovering COVID-19 spillovers. She talked about the wide spectrum impact of COVID-19 on cancer patients, and how the focus from Non-Communicable Diseases (NCDs) to communicable diseases stressed health resources and redirected resource mobilization efforts. She went on to say that in an emergency situation, agile adaptive service delivery is the key to uninterrupted care. She also touched on patient and staff safety and the importance of a tailored communication strategy amid the pandemic. Ms. Qatamish concluded her presentation by emphasizing that a pandemic does not end cancer and that health systems can grow stronger post COVID-19.

Following the presentations, Dr. Lami and Dr. Alwan moderated a Q&A session in which participants interacted with the speakers.